NYSE American - Nasdaq Real Time Price USD

Matinas BioPharma Holdings, Inc. (MTNB)

0.9300
+0.0101
+(1.10%)
As of 10:12:03 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
1,096
3,188
33
Operating Expense
16,206
20,162
24,862
27,778
24,768
Operating Income
-16,206
-20,162
-23,766
-24,590
-24,735
Other Income Expense
-3,957
-4,169
824
3,593
1,452
Pretax Income
-20,163
-24,331
-22,942
-20,997
-23,283
Tax Provision
--
-80
0
--
--
Net Income Common Stockholders
-20,083
-24,251
-22,942
-20,997
-23,679
Diluted NI Available to Com Stockholders
-20,083
-24,251
-22,942
-20,997
-23,679
Basic EPS
-3.97
-4.98
-5.28
-5.00
-5.50
Diluted EPS
-3.97
-4.98
-5.28
-5.00
-5.50
Basic Average Shares
5,050.7850
4,865.8290
4,345.2910
4,336.2280
4,203.5660
Diluted Average Shares
5,050.7850
4,865.8290
4,345.2910
4,336.2280
4,203.5660
Total Operating Income as Reported
-20,637
-24,593
-23,766
-24,590
-24,735
Total Expenses
16,206
20,162
24,862
27,778
24,768
Net Income from Continuing & Discontinued Operation
-20,083
-24,251
-22,942
-20,997
-23,283
Normalized Income
-15,946
-19,834.6223
-23,426
-24,488
-24,611
EBIT
-16,206
-20,162
-23,766
-24,590
-24,735
EBITDA
-15,346
-19,190
-22,825
-23,692
-23,954
Reconciled Depreciation
860
972
941
898
781
Net Income from Continuing Operation Net Minority Interest
-20,083
-24,251
-22,942
-20,997
-23,283
Total Unusual Items Excluding Goodwill
-4,137
-4,431
484
3,491
1,328
Total Unusual Items
-4,137
-4,431
484
3,491
1,328
Normalized EBITDA
-11,209
-14,759
-23,309
-27,183
-25,282
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
-14.6223
0
0
0
12/31/2021 - 7/21/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ENTO Entero Therapeutics, Inc.
0.5232
+0.60%
 
ZVSA ZyVersa Therapeutics, Inc.
0.6355
-2.96%
 
PCSA Processa Pharmaceuticals, Inc.
0.3161
+5.09%
 
BDRX Biodexa Pharmaceuticals Plc
1.1301
-1.73%
 
BCLI Brainstorm Cell Therapeutics Inc.
1.2100
-0.82%
 
ENVB Enveric Biosciences, Inc.
1.3100
-0.55%
 
KAPA Kairos Pharma, Ltd.
0.4800
+2.08%
 
RENB Renovaro Inc.
0.3200
+3.59%
 
EQ Equillium, Inc.
0.3702
-2.58%
 
AEON AEON Biopharma, Inc.
0.9042
+9.57%